Zineb Abdelkarim Ammous

Zineb Abdelkarim Ammous ( ZINEB ABDELKARIM AMMOUS ) is A Medical Genetics Physician in Topeka, IN. The NPI Number for Zineb Abdelkarim Ammous is 1174751218.

The current location address for Zineb Abdelkarim Ammous is 315 LEHMAN AVE #C Topeka, IN 46571 and the contact number is 2605930108 and fax number is 2605930116. The mailing address for Zineb Abdelkarim Ammous is 315 LEHMAN AVE #C PO BOX 9 Topeka, IN 46571- 2605930108 (mailing address contact number - 2605930108).

A clinical geneticist demonstrates competence in providing comprehensive diagnostic, management and counseling services for genetic disorders.

What is the NPI Number for Zineb Abdelkarim Ammous ?

Answer: The NPI Number for Zineb Abdelkarim Ammous is 1174751218

Where is Zineb Abdelkarim Ammous located?

Answer: Zineb Abdelkarim Ammous is located at 315 LEHMAN AVE #C Topeka, IN 46571.

What is the specialty for Zineb Abdelkarim Ammous ?

Answer: The Specialty of Zineb Abdelkarim Ammous is A Medical Genetics Physician.

Are there any online reviews for Zineb Abdelkarim Ammous ?

Answer: Not yet!

Are there any other health care providers in Topeka, IN?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Medical Genetics and Genomics
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	19
Number of Standardized 30-Day Fills	23
Aggregate Cost Paid for All Claims	156640.61
Number of Day's Supply for All Claims	690
Number of Medicare Beneficiaries
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	17
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst	*
Total Claims of Generic Drugs, Including Refills
Aggregate Cost Paid for Generic Drugs
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	#
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	0
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	0
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	19
Aggregate Cost Paid for Claims Filled by	156640.61
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	19
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	156640.61
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	0
by Low-Income Subsidy	0
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	0
Aggregate Cost Paid for Antibiotic Drugs	0
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	42.666666667
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	2.179